David Chiswell

Chiswell, 65, was head of one of Britain’s most successful life sciences companies, Cambridge Antibody Technology. He went on to found and chair Kymab, which develops drugs with the help of mice genetically engineered to produce human antibodies. He is now adviser to the firm, which has had $100m of investment from backers such as Shenzhen Hepalink Pharmaceutical.

Maserati S.p.A.
Viale Ciro Menotti, 322 – 41121, Modena (MO), Italy

Company registered under Italian law - VAT: IT 08245890010 R.E.A. Modena 347990

Share capital: 80.000.000 €, fully paid-up
Direction and coordination under Article 2497 of the Italian Civil Code: Stellantis N.V.

maserati@pec.fcagroup.com
www.maserati.com